A series of groundbreaking studies from Poland have shed new light on the prevalence and impact of lipoprotein(a) [Lp(a)] on cardiovascular health, prompting calls for routine measurement of this important biomarker.
Researchers at Weill Cornell Medicine have utilised advanced machine learning techniques to identify three distinct subtypes of Parkinson’s disease, potentially paving the way for more personalised treatment approaches.
The National Institutes of Health (NIH) and VentureWell have awarded prizes totalling $160,000 to 11 winning teams and five honourable mentions in the 13th annual Design by Biomedical Undergraduate Teams (DEBUT) Challenge.
A groundbreaking method for monitoring antibiotic-resistant bacteria in hospitals could improve infection control and patient care.
Vitestro, a Dutch medical robotics firm, has announced that its autonomous blood drawing device has received CE marking, making it the first such device to be approved for commercial use in the European Union. This milestone, achieved in July 2024, signifies the device’s compliance with the European Medical Device Regulation (MDR) standards for safety and […]
A groundbreaking neuroimaging study has identified distinct patterns of brain activation associated with various forms of love, offering new insights into the neural underpinnings of this complex emotion.
Researchers at the RIKEN Center for Brain Science in Japan have identified a new type of grid cell in the brain that predicts an animal’s future position, shedding light on how we navigate a spatial environment.
A comprehensive analysis of FDA-approved artificial intelligence medical devices reveals significant gaps in clinical validation, raising concerns about their effectiveness and safety in real-world healthcare settings.
Roy and Diana Vagelos make history with the largest single donation to Columbia’s medical school, set to transform biomedical science research and education.
Researchers from German universities have identified a new class of molecules that could pave the way for innovative tuberculosis treatments, offering hope in the face of rising antibiotic resistance.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
